Fennec Pharmaceuticals Inc. (FENC)

Fennec Pharmaceuticals Revenue

Fennec Pharmaceuticals had revenue of $19.61M in the quarter ending September 30, 2026, with 57.34% growth. This brings the company's total for the last twelve months to $66.37M, up 71.09% year-over-year. In the year 2025, Fennec Pharmaceuticals had annual revenue of $44.64M, down -6.09%. That makes Fennec Pharmaceuticals the 25,878th largest company in the world by revenue and 3,574th in the United States.

• Revenue (ttm): $66.37M
• Revenue Growth: +71.09%
• P/S Ratio: 6.18
• Revenue / Employee: $1,896,200
• Employees: 35
• Market Cap: 410.25M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	44.64M	-2.90M	-6.09%
Dec 31, 2024	47.54M	26.29M	123.69%
Dec 31, 2023	21.25M	19.72M	1,284.50%
Dec 31, 2022	1.54M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error